Department of Emergency Medicine, Centre Hospitalier Universitaire Fatouma Bourguiba, Rue du 1er Juin, Monastir, Tunisia.
Am J Emerg Med. 2011 Feb;29(2):203-6. doi: 10.1016/j.ajem.2009.09.019. Epub 2010 Oct 8.
We tested whether paracetamol could improve pain relief in patients visiting the emergency department with acute renal colic as compared to piroxicam, a nonsteroidal anti-inflammatory drug (NSAID).
Patients with a diagnosis of acute renal colic were prospectively randomized to receive either intravenous paracetamol (1 g) or intramuscular piroxicam (20 mg). We monitored patients for visual analog scale (VAS), heart rate, arterial blood pressure, need for rescue therapy, and adverse events at different time points for 90 minutes. We recorded admission requirement and new visit for renal colic at 72 hours. The primary end point was pain relief at 90 minutes, defined as a decrease of 50% or more as compared to the initial VAS. The secondary objectives were comparison of the 2 groups for VAS at any time points and the occurrence of adverse events.
Of the 226 eligible patients, 100 entered the study. Fifty patients received paracetamol and 50 received NSAID. Pain relief at 90 minutes was obtained in 40 patients receiving paracetamol (80%) and 24 (48%) receiving NSAID (P = .002). Visual analog scale was lower in the paracetamol group since 45 minutes. Only 2 adverse events were observed.
A single therapy with intravenous paracetamol more efficiently relieved pain in acute renal colic than did intramuscular piroxicam.
我们检测了与非甾体抗炎药(NSAID)吡罗昔康相比,扑热息痛是否能改善因急性肾绞痛而就诊急诊的患者的疼痛缓解程度。
将诊断为急性肾绞痛的患者前瞻性随机分为静脉注射扑热息痛(1 克)或肌内注射吡罗昔康(20 毫克)。我们在 90 分钟内的不同时间点监测患者的视觉模拟量表(VAS)、心率、动脉血压、是否需要抢救治疗以及不良反应。我们记录入院要求和 72 小时内的肾绞痛新就诊情况。主要终点为 90 分钟时的疼痛缓解,定义为与初始 VAS 相比降低 50%或更多。次要目标是比较两组在任何时间点的 VAS 以及不良反应的发生情况。
在 226 名符合条件的患者中,有 100 名进入了研究。50 名患者接受了扑热息痛治疗,50 名患者接受了 NSAID 治疗。接受扑热息痛治疗的 40 名患者中有 40 名(80%)在 90 分钟时疼痛缓解,而接受 NSAID 治疗的 50 名患者中有 24 名(48%)(P =.002)。扑热息痛组从 45 分钟开始 VAS 就更低。仅观察到 2 例不良反应。
单次静脉注射扑热息痛比肌内注射吡罗昔康更有效地缓解急性肾绞痛的疼痛。